A. D. Fryer, D. B. Jacoby (1998). Muscarinic receptors and control of airway smooth muscle.
Am. J. Respir. Crit. Care Med. 158: S154.
K. Fukuda, T. Kubo, I. Akiba, A. Maeda, M. Mishima, S. Numa (1987). Molecular distinction
between muscarinic acetylcholine receptor subtypes. Nature 327: 623–625.
H. C. Hartzell (1982). Physiological consequences of muscarinic receptor activation. In: J. W.
Lamble (Ed.). More About Receptors. Amsterdam: Elsevier Biomedical Press.
R. C. Hogg, D. Bertrand (2004). Nicotinic acetylcholine receptors as drug targets. Curr. Drug
Targ.: CNS Neurol. Disorders 3: 123–130.
V. Itier, D. Bertrand (2001). Neuronal nicotinic receptors: from protein structure to function.
FEBS Lett. 504 : 118–125.
A. Karlin, P. N. Kao, M. DiPaola (1986). Molecular pharmacology of the nicotinic acetylcholine
receptor. Trends Pharmacol. Sci. 7: 304–308.
D. A. Kharkevich (1981). Main trends in the search for new neuromuscular blocking agents.
Trends Pharmacol. Sci. 2: 218–220.
J. Kistler, R. M. Stroud, M. W. Klymkowsky, R. A. Lalancette, R. H. Fairclough (1982). Structure
and function of an acetylcholine receptor. Biophys. J. 37: 371–378.
R. R. Levine, N. J. M. Birdsall, N. M. Nathanson (1999). Subtypes of muscarinic receptors. Life
Sci. 64: 355.
J. P. Margiotta, P. C. Pugh (2004). Nicotinic acetylcholine receptors in the nervous system. Adv.
Mol. Cell Biol. 32: 269–302.
M. P. McCarthy, J. P. Ernest, E. F. Young, J. Choe, R. M. Stroud (1986). The molecular neurobi-
ology of the acetylcholine receptor. Annu. Rev. Neurosci. 9: 383–413.
M. Noda, H. Takahashi, T. Tanabe, M. Toyosato, Y. Furutani, T. Hirose, M. Asak, S. Inayama,
T. Miyata, S. Numa (1982). Primary structure of α-subunit precursor of Torpedo californica
acetylcholine receptor from cDNA sequence. Nature 299: 793–802.
A. Noma (1986). GTP-binding proteins couple cardiac muscarinic receptors to potassium chan-
nels.Trends Neurol. Sci. 10: 142–143.
K. Peper, R. J. Bradley, F. Dryer (1982). The acetylcholine receptor at the neuromuscular junc-
tion.Physiol. Rev. 62: 1271–1340.
J. L. Popot, J.-P. Changeux (1984). Nicotinic receptor of acetylcholine: structure of an oligomeric
integral membrane protein. Physiol. Rev. 64: 1162–1239.
J. D. Schmitt, M. Bencherif (2000). Targeting nicotinic acetylcholine receptors: advances in mol-
ecular design and therapies. Ann. Rep. Med. Chem. 35: 41.
J. P. Snyder (1985). Molecular models for muscarinic receptors. Trends Pharmacol. Sci. 6: 464–466.
S. H. Snyder (1984). Drug and neurotransmitter receptors in the brain. Science 224: 22–31.
E. R. Spindel (2003). Neuronal nicotinic acetylcholine receptors: not just in brain. Am. J. Physiol.
285 : L1201–L1202.
J. C. Venter (1983). Muscarinic receptor structure. J. Biol. Chem. 258: 4842–4848.
V. P. Whittaker (1986). The storage and release of acetylcholine. Trends Pharmacol. Sci. 7:
312–315.
Norepinephrine and Adrenergic Receptors
R. Aantaa, A. Marjamaki, M. Scheinin (1995). Molecular pharmacology of alpha 2-adrenoceptor
subtypes.Ann. Med. 27: 439.
M. R. Bristow (1997). Mechanism of action of β-blocking agents in heart failure. Am. J. Cardiol.
80 : 26L.
A. K. Cho, G. S. Takimoto (1985). Irreversible inhibitors of adrenergic nerve terminal function.
Trends Pharmacol. Sci. 6: 443–447.
300 MEDICINAL CHEMISTRY